Effects of Immulina TM Supplements With PASC Patients
NCT05524532
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
101
Enrollment
OTHER
Sponsor class
Conditions
Post Acute COVID-19 Syndrome
Interventions
DRUG:
Immulina TM
DIETARY_SUPPLEMENT:
Placebo
Sponsor
University of Mississippi Medical Center
Collaborators
[object Object]